Hympavzi Side Effects
Generic name: marstacimab
Medically reviewed by Drugs.com. Last updated on Apr 10, 2025.
Note: This document provides detailed information about Hympavzi.
Applies to marstacimab: parenteral prefilled pen and syringe Side Effects associated with marstacimab. Some dosage forms listed on this page may not apply specifically to the brand name Hympavzi.
Applies to marstacimab: parenteral prefilled pen and syringe.
Side effects include:
Most common adverse reactions (≥3%): injection site reaction, headache, pruritus.
For healthcare professionals
Applies to marstacimab: subcutaneous solution.
Cardiovascular adverse events
- Frequency not reported: Thromboembolic events[Ref]
Dermatologic
- Common (1% to 10%): Pruritus[Ref]
Hypersensitivity
- Frequency not reported: Hypersensitivity, peripheral swelling[Ref]
Local
- Common (1% to 10%): Injection site reaction[Ref]
Nervous system
- Common (1% to 10%): Headache[Ref]
See also:
References
1. (2024) "Product Information. Hympavzi Pre-filled Pen (marstacimab)." Pfizer U.S. Pharmaceuticals Group
More about Hympavzi (marstacimab)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Hympavzi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.